- Eli Lilly press release (NYSE:LLY): Q2 Non-GAAP EPS of $6.31 beats by $0.72.
- Revenue of $15.56B (+37.7% Y/Y) beats by $890M.
- Revenue in Q2 2025 increased 38% to $15.56 billion driven by volume growth from Zepbound and Mounjaro.
- FY25 revenue
Eli Lilly Non-GAAP EPS of $6.31 beats by $0.72, revenue of $15.56B beats by $890M
